Beta 2 Adrenergic Receptor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ADRB2 |
|---|
| Protein Name | Beta-2 Adrenergic Receptor |
|---|
| Gene | ADRB2 |
|---|
| UniProt ID | P07550 |
|---|
| PDB IDs | 2RHY, 3KJ6, 4G5R |
|---|
| Molecular Weight | 46.5 kDa |
|---|
| Subcellular Localization | Plasma Membrane |
|---|
| Protein Family | G Protein-Coupled Receptor (GPCR) - Adrenergic Receptor Family |
|---|
The beta-2 adrenergic receptor (β2-AR) is a G protein-coupled receptor that responds to epinephrine and norepinephrine. It is widely expressed in the central nervous system and peripheral tissues, where it regulates diverse physiological processes including bronchodilation, vasodilation, glycogenolysis, and lipolysis. In the brain, β2-AR is expressed in regions involved in memory consolidation and emotional processing, including the hippocampus, amygdala, and prefrontal cortex.
The β2-AR is a prototypical class A GPCR consisting of seven transmembrane helices (TM1-TM7) connected by three extracellular loops (ECL1-ECL3) and three intracellular loops (ICL1-ICL3). The receptor contains:
- N-terminal extracellular domain: Short, glycosylated
- Transmembrane domain: Seven α-helices forming the ligand-binding pocket
- Intracellular domain: Couples to G proteins and contains phosphorylation sites
- C-terminal tail: Palmitoylated for membrane anchoring
- Agonist binding → conformational change in receptor
- Gαs coupling → activation of adenylyl cyclase
- cAMP production → activation of protein kinase A (PKA)
- Phosphorylation of target proteins → cellular responses
- β-arrestin recruitment after phosphorylation
- Receptor internalization
- β-arrestin-dependent signaling (MAPK activation)
- Gαs/ Golf: Primary G protein coupling
- β-arrestin 1/2: For desensitization and signaling
- GRK2/3/5/6: For receptor phosphorylation
- Hippocampus: CA1-CA3 pyramidal neurons, dentate gyrus
- Cortex: Layer V pyramidal neurons
- Amygdala: Basolateral and central nuclei
- Cerebellum: Purkinje cells
- Thalamus: Various nuclei
- Locus coeruleus: Noradrenergic neurons
- Lung bronchial smooth muscle
- Cardiac myocardium
- Skeletal muscle
- Adipose tissue
- Liver
- Memory consolidation: β2-AR in hippocampal LTP and memory
- Aβ effects: Aβ may dysregulate β2-AR signaling
- Neuroinflammation: β2-AR modulates microglial activation
- Therapeutic potential: β2-agonists being investigated
- Neuroprotection: β2-AR activation may protect dopaminergic neurons
- L-dopa response: Altered β2-AR signaling in PD
- Olfactory dysfunction: β2-AR in olfactory bulb
- Depression: β2-AR in mood regulation
- Anxiety: Stress-induced β2-AR changes
- ADHD: Noradrenergic modulation
| Drug |
Application |
Status |
| Albuterol |
Asthma, bronchodilation |
Approved |
| Formoterol |
Long-acting bronchodilator |
Approved |
| Salmeterol |
Asthma/COPD |
Approved |
| Terbutaline |
Bronchodilation |
Approved |
| Drug |
Application |
Status |
| Propranolol |
Hypertension, anxiety |
Approved |
| Metoprolol |
Hypertension, HF |
Approved |
| Atenolol |
Hypertension |
Approved |
| Carvedilol |
HF, hypertension |
Approved |
- Clenbuterol: Brain-penetrant β2-agonist (research)
- ICI-118551: Selective β2-antagonist (research)
- Tremor (muscle β2-AR activation)
- Tachycardia (cardiac β1-AR activation)
- Hypokalemia (β2-AR in liver)
- Hyperglycemia (β2-AR in liver)
- β-blockers may blunt epinephrine response
- Cocaine + β-agonists = cardiovascular risk
- ADRB2 knockout mice: Altered stress response, memory deficits
- Overexpression studies: Enhanced memory consolidation
- β2-AR antagonists: Impaired remote memory
The study of Beta 2 Adrenergic Receptor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- 1 ADRB2 protein. UniProtKB. Retrieved 2026-03-04.
- 2 PDB: 2RHY, 3KJ6. Retrieved 2026-03-04.
- 3 Strosberg AD. (1993). Structure, function, and regulation of adrenergic receptors. Protein Sci.
- 4 Lefkowitz RJ. (2013). History of β-adrenergic receptor research. J Biol Chem.
- 5 Ramos BP, Arnsten AF. (2007). Adrenergic pharmacology and cognition. Pharmacol Rev.
- 6 Yu G, et al. (2018). β2-adrenergic receptor in Alzheimer's disease. J Alzheimers Dis.
- 7 O'Donnell J, et al. (2012). β2-AR and neuroinflammation. Brain Behav Immun.
- 8 Summers RJ, et al. (2005). β2-AR in CNS function. Neuropharmacology.